PULM (PULM) Stock Price & Analysis
PULM (PULM) rose 0.45% to USD 1.39 as of September 8, 2026 at 06:55 UTC, according to Nexqual real-time market data.
PULM last closed at USD 1.39; the session ranged USD 1.36–1.45 on volume of 20,147 shares. Market capitalization is —, with a 52-week range of USD 1.16–5.5 (NCM). Source: Nexqual, September 8, 2026 at 06:55 UTC.
Key Statistics (as of September 8, 2026 at 06:55 UTC)
| Price | USD 1.39 |
|---|---|
| Change | ▲ 0.45% (up) |
| Previous Close | USD 1.39 |
| Open | USD 1.39 |
| Day Range | USD 1.36 – 1.45 |
| 52-Week Range | USD 1.16 – 5.5 |
| Volume | 20,147 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (PULM)
Nexqual's technical model rates PULM "SELL" based on 2 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 06:55 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 36 (neutral) |
| vs SMA50 | Below (USD 1.62) |
| MACD | -0.05 (negative) |
From PULM's Latest SEC 10-K Filing (filed 2026-02-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BNTC | Benitec Biopharma Inc. | USD 12.68 | ▼ 1.55% |
| IDXGD | Interpace Biosciences, Inc. | USD 6.91 | ▼ 0.96% |
| TENX | Tenax Therapeutics, Inc. | USD 1.94 | ▲ 4.86% |
| MBRX | Moleculin Biotech, Inc. | USD 0.71 | ▲ 2.29% |
| CLRB | Cellectar Biosciences, Inc. | USD 2.37 | ▼ 2.47% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:55 UTC. This page is informational and not investment advice.